Business Context and Reporting Period
HealthCor Catalio Acquisition Corp., a Cayman Islands special purpose acquisition company, filed this Form 8-K on August 11, 2021, reporting management and board changes. The filing does not provide operating or financial results for a reporting period.
Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes
- Christopher Gaulin resigned as Chief Executive Officer and a director, effective August 11, 2021. The filing states that his resignation was not due to any disagreement with the company.
- Art Cohen was appointed Chief Executive Officer and a director, effective immediately.
- Avi Horev resigned as a director. The filing states that his resignation was not due to any disagreement with the company.
- Benjamin Snedeker was appointed to the board of directors.
Management Commentary, Risks, and Unusual Items
Art Cohen is a co-founder and portfolio manager of HealthCor Management, L.P. The company cited his transactional and healthcare investment experience as qualifying him to serve on the board. The filing discloses no family relationships or reportable related-party transactions involving Mr. Cohen or Mr. Snedeker.
No guidance, outlook, contingencies, litigation, or unusual financial items are disclosed. The leadership transition may be relevant to the company’s execution of its acquisition strategy, but the filing does not describe any specific effect.
Investor Verification Items
- Verify the effective dates and scope of the CEO and director appointments and resignations.
- Review subsequent filings for additional changes in board composition, executive responsibilities, or acquisition strategy.
- Confirm that the filing’s registrant is HealthCor Catalio Acquisition Corp.; the provided request metadata references Hyperfine, Inc., which is not the registrant named in the filing text.